Product Description
This digital document is an article from BIOTECH Patent News, published by Thomson Gale on September 1, 2006. The length of the article is 654 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth.Author: Gale Reference TeamPublication: BIOTECH Patent News (Newsletter)Date: September 1, 2006Publisher: Thomson GaleVolume: 20 Issue: 9Distributed by Thomson Gale